Key Highlights

  • Park Ha Biological Technology (NASDAQ:BYAH) was trading up 10.86% at USD 1.63 in pre-market on Friday, November 13, 2026, according to pre-market market data, with no company announcement explaining the move found.
  • The USD 1.63 quote is below the 52-week low of USD 1.90 shown in published data as of October 21, 2026, when the stock had last been quoted near USD 2.21 pre-market.
  • Trailing twelve-month Revenue was about USD 2.54 million, down 8.1%, against a net loss of about USD 5.45 million, with a Market Value near USD 8.12 million and 3.43 million shares as of October 21.
  • A 1-for-50 reverse split took effect on February 16, 2026, and the company closed a USD 2.0 million registered direct offering on June 15, 2026.

A Pre-Market Bounce Without a Company Announcement

Park Ha Biological Technology (NASDAQ:BYAH) was trading up 10.86% at USD 1.63 in pre-market on Friday, November 13, 2026. That is the screener figure of record, and the prior close is not confirmed here. After searching company releases and filings, no announcement dated November 11 to November 13, 2026 that explains the move was found. The calculated implied prior close is about USD 1.47. A move of this size in a thin, sub-USD 5 stock can come from a handful of trades, so it is not by itself news. The article therefore rests on the last verified filings, offerings and published figures, and says so plainly.

A Small Skincare Business and a String of Partnership Headlines

The company develops skincare products in China under the Park Ha brand, with a Product Sales segment and a Franchise Service segment, selling through its own stores and franchisees. It listed on Nasdaq in December 2024. In June 2026 it announced an AI-driven skincare tie-up with a Subsidiary of Star Plus Legend, a second AI beauty partnership with a Hong Kong-listed company and a cooperation to enter the North American market through Amazon. The June 12 announcement was followed by a registered direct offering that closed on June 15. Plaintiff law firms also circulated class action reminders in August and September 2026.

Dilution History, Thin Revenue and a Price Under Prior Lows

The share count is small after the reverse split, so each new offering matters. Published data shows the 52-week range running from USD 1.90 to USD 169.40, a spread that largely reflects split adjustments, and the current quote sits below that low. Revenue of about USD 2.54 million does not cover a net loss of about USD 5.45 million. Registration statements were filed in April, May and June 2026, and a further raise would add shares. The company has also faced a securities class action notice. A quoted bounce can reverse, spreads can be wide and nothing here implies it will continue. Readers should treat every quoted figure as a snapshot, not a forecast.

Where Things Stand

Most likely it is a trading bounce rather than news, because no company-specific catalyst was found for November 11 to November 13, 2026. Park Ha Biological Technology (NASDAQ:BYAH) is a micro-cap skincare seller with falling revenue, a net loss larger than sales, a reverse split in February and a June offering. The stock is quoted below its prior 52-week low in published data. What to watch next are any new filings or offerings, a Nasdaq compliance notice and whether the company publishes fresh results.